PTC THERAPEUTICS, INC. — Director's Dealing 2020

Jan 31, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2020-01-29

Reporting Person: Utter Christine Marie (SVP, Finance & CAO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-01-29	Common Stock	A	4080	—	Acquired	9304	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-01-29	Stock Option (Right To Buy)	$51.16	A	23800	Acquired	2030-01-28	Common Stock (23800.0)	Direct

Footnotes

F1: Restricted stock units granted on January 29, 2020 that vest in four equal installments over four years, commencing on January 29, 2021.

F2: This option was granted on January 29, 2020, and vests over four years, with 25% of the shares underlying the option vesting on January 29, 2021, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 29, 2021.